The C allele has been associated with enhanced pathologic complete response to neoadjuvant chemotherapy/HER2 targeted treatment in non-diabetic HER2 + BC subjects15 receiving metformin; this SNP associated effect may have been mediated by mechanisms that differed from the metabolic mechanisms we investigated here. This evidence concerns the gene ERBB2 and breast cancer.